Panacea Index Logo

Command Palette

Search for a command to run...

Treatment strategies for complex behavioral insomnia in children with neurodevelopmental disorders.

Current opinion in pulmonary medicine
November 1, 2013
Madeleine Grigg-Damberger et al. (2 authors)
Journal ArticleReviewHuman Study
Study Details

Study Goal

The researchers aimed to review the benefits of melatonin in treating sleep problems in children with neurodevelopmental disorders (NDDs).

Results Summary

The study found that melatonin, alongside behavioral therapies, is beneficial for treating sleep problems in children with NDDs, particularly in complex and chronic cases. It highlighted the prevalence of sleep issues in specific neurodevelopmental syndromes like Rett, Angelman, Williams, and Smith-Magenis.

Population

Children and adolescents with neurodevelopmental disorders, including autism spectrum disorder (ASD) and specific syndromes (Rett, Angelman, Williams, and Smith-Magenis).

Effective Dosage

Not specified

Duration

Not specified

Interactions

None mentioned

Extracted Claims (4)
InterventionDirectionEndpointPopulationDosageImpactClaim #
behavioral therapies
decrease
sleep problems
children with NDD
-
review the benefits
#1
melatonin
decrease
sleep problems
children with NDD
-
review the benefits
#2
treatment
increase
well being
those affected by NDD and their families
-
provides an opportunity to improve
#3
treatment
increase
quality of life
those affected by NDD and their families
-
provides an opportunity to improve
#4
Abstract

PURPOSE OF REVIEW: This review describes recent research in pediatric behavioral insomnias in neurodevelopmental disorders and their treatment. RECENT FINDINGS: Insomnia in children with autism spectrum disorder (ASD) and other neurodevelopmental disorders (NDDs) is typically complex, chronic, and difficult to adequately control. Abnormalities in genetic and/or epigenetic regulation of sleep/wakefulness and its timing predispose patients with NDD to insomnia, although poor sleep hygiene, maladaptive associations, and limit-setting are likely to contribute. Parents are agents for change in problematic sleep behaviors in patients with NDD. We review the benefits of behavioral therapies and melatonin to treat sleep problems in children with NDD. Problematic sleep is so prevalent in some neurodevelopmental syndromes (Rett, Angelman, Williams, and Smith-Magenis) that it is part of their diagnostic criteria. SUMMARY: Children and adolescents with neurological disorders frequently have complex sleep disorders that require treatment. Understanding the basic pathology and treatment strategies provides an opportunity to improve well being and quality of life in those affected by NDD and their families.

Medical Subject Headings (MeSH)
Angelman SyndromeCentral Nervous System DepressantsChildChild Development Disorders, PervasiveChild, PreschoolChronic DiseaseCognitive Behavioral TherapyFemaleHumansMaleMelatoninParentsQuality of LifeRett SyndromeSleep Initiation and Maintenance DisordersSmith-Magenis SyndromeSurveys and QuestionnairesTreatment OutcomeWilliams Syndrome
Study Links
Quality Scores
SafetyNot Assessed
Efficacy75/10
Quality80/10
Citation Metrics
Total Citations36
Citations/Year3.0
Relative Citation Ratio1.66
NIH Percentile68.6%
Research Impact Scores
APT Score0.75
Weight Score1.59
Normalized Score0.66
Related Supplements